Log in to save to my catalogue

You just heard another alarming health report. Should you be scared? (Posted 2016-01-04 18:02:26): H...

You just heard another alarming health report. Should you be scared? (Posted 2016-01-04 18:02:26): H...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1753275750

You just heard another alarming health report. Should you be scared? (Posted 2016-01-04 18:02:26): Here are some ways to evaluate whether studies apply to you or not

About this item

Full title

You just heard another alarming health report. Should you be scared? (Posted 2016-01-04 18:02:26): Here are some ways to evaluate whether studies apply to you or not

Publisher

Washington, D.C: WP Company LLC d/b/a The Washington Post

Journal title

The Washington post (Washington, D.C. 1974. Online), 2016-01-01

Language

English

Publication information

Publisher

Washington, D.C: WP Company LLC d/b/a The Washington Post

More information

Scope and Contents

Contents

Prescription tamoxifen or raloxifene may lower breast cancer risk in post-menopausal women; tamoxifen may do the same in high-risk premenopausal women. Prescription aromatase inhibitors may cut the likelihood of breast cancer in high-risk, post-menopausal women and prevent a recurrence in breast-cancer survivors.

Alternative Titles

Full title

You just heard another alarming health report. Should you be scared? (Posted 2016-01-04 18:02:26): Here are some ways to evaluate whether studies apply to you or not

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1753275750

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1753275750

Other Identifiers

ISSN

0190-8286

E-ISSN

2641-9599

How to access this item